HANGZHOU INNOGATE PHARMA CO LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	China	11
#2	WIPO (World Intellectual Property Organization)	11
#3	United States	8
#4	EPO (European Patent Office)	6
#5	Australia	1
#6	Republic of Korea	1
#7	Taiwan	1

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Medical preparations
#4	Climate change mitigation in goods production
#5	Organic chemistry methods

Publication	Filing date	Title
WO2020188467A1	2020-03-16	Condensed tricyclic compound used as kinase inhibitor
WO2020114519A1	2019-12-09	Heterocyclic compound as cdk-hdac dual pathway inhibitor
WO2020108661A1	2019-12-02	Heterocyclic compound as cdk-hdac double-channel inhibitor
CN109843872A	2018-09-20	As IDO inhibitor and/or the polycyclic compound of IDO-HDAC double inhibitor
US2020079795A1	2017-12-12	Heterocyclic compound as syk inhibitor and/or syk-hdac dual inhibitor
CN110746443A	2017-12-12	Tricyclic heteroaryl-containing compounds
CN109153678A	2017-05-27	Heterocyclic compound as FGFR4 inhibitor
CN109071521A	2017-01-09	Heterocyclic compound as FGFR inhibitor
EP3386981A1	2016-12-13	Heterocycles useful as anti-cancer agents
CN107056785A	2016-10-13	It is used as the heterocyclic compound of IDO and TDO inhibitor
CN107709336A	2016-06-12	As Syk inhibitor and/or the heterocyclic compound of Syk HDAC double inhibitors
AU2016248366A1	2016-04-12	Heterocycles useful as IDO and TDO inhibitors